Diffuse large B-cell lymphoma in the maxillary sinus: case report
DOI:
https://doi.org/10.37085/jmmv8.n1.2026.pp.1-5Keywords:
Lymphoma, Maxillary sinus, Diffuse Large B-cell LymphomaAbstract
Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of non-Hodgkin lymphoma, accounting for 30-40% of cases. Symptoms are nonspecific and can range from nasal obstruction to visual disturbances, making diagnosis difficult and easily confused with benign inflammatory conditions and upper respiratory tract infections. In this article, we report the case of a 79-year-old female patient who sought care due to frontal headache and left hemifacial pain. After imaging studies, which revealed an infiltrative lesion in the maxillary sinus extending to the nasal cavity, orbit, and lateral wall, and biopsy, the patient was diagnosed with diffuse large B-cell lymphoma and referred for oncological treatment. The signs and clinical manifestations of diffuse large B-cell lymphoma (DLBCL) in the maxillary sinus are nonspecific. Diagnosis requires biopsy for evaluation, showing high proliferation of large B cells, with fibrosis and necrosis. Initial treatment for DLBCL involves chemotherapy using monoclonal antibodies.
Downloads
References
1. Singh R, Shaik S, Negi B, Rajguru J, Patil P, Parihar A, et al. Non-Hodgkin’s lymphoma: A review. J Family Med Prim Care 2020;9:1834. Doi:10.4103/jfmpc.jfmpc_1037_19.
2. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. The Lancet 2012;380:848–57. Doi:10.1016/S0140-6736(12)60605-9.
3. Melo A, Rangel N, Oliveira I, Nascimento J, Oliveira R. Linfoma difuso de grandes células B em maxila: relato de caso. Hematol Transfus Cell Ther 2023;45:S347–8. Doi:10.1016/j.htct.2023.09.671.
4. López-Guillermo A, Colomo L, Jiménez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin. Journal of Clinical Oncology 2005;23:2797–804. Doi:10.1200/JCO.2005.07.155.
5. Varelas AN, Eggerstedt M, Ganti A, Tajudeen BA. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B ‐cell lymphoma. Laryngoscope 2019;129:1259–64. Doi:10.1002/lary.27639.
6. Susanibar‐Adaniya S, Barta SK. 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management. Am J Hematol 2021;96:617–29. Doi:10.1002/ajh.26151.
7. Kanumuri V V., Khan MN, Vazquez A, Govindaraj S, Baredes S, Eloy JA. Diffuse large B-cell lymphoma of the sinonasal tract: Analysis of survival in 852 cases. Am J Otolaryngol 2014;35:154–8. Doi:10.1016/j.amjoto.2013.09.003.
8. Usuda D, Izumida T, Terada N, Sangen R, Higashikawa T, Sekiguchi S, et al. Diffuse large B cell lymphoma originating from the maxillary sinus with skin metastases: A case report and review of literature. World J Clin Cases 2021;9:6886–99. Doi:10.12998/wjcc.v9.i23.6886.
9. Janardhanan M, Suresh R, Savithri V, Veeraraghavan R. Extranodal diffuse large B cell lymphoma of maxillary sinus presenting as a palatal ulcer. BMJ Case Rep 2019;12:bcr-2018-228605. Doi:10.1136/bcr-2018-228605.
10. O’Connor RM, Vasey M, Smith JC. Diffuse large B-cell lymphoma of the maxillary sinus. Ear Nose Throat J 2010;89:E8-10.
11. Taylor MA, Saba NF. Cancer of the Paranasal Sinuses. Hematol Oncol Clin North Am 2021;35:949–62. Doi:10.1016/j.hoc.2021.05.006.
12. Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck. Neuroimaging Clin N Am 2003;13:371–92. Doi:10.1016/S1052-5149(03)00039-X.
13. Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology 2018;50:74–87. Doi:10.1016/j.pathol.2017.09.006.
14. Harrington F, Greenslade M, Talaulikar D, Corboy G. Genomic characterisation of diffuse large B-cell lymphoma. Pathology 2021;53:367–76. Doi:10.1016/j.pathol.2020.12.003.
15. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology 2014;32:3048–58. Doi:10.1200/JCO.2013.53.5229.
16. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011;43:830–7. Doi:10.1038/ng.892.
17. Cabanillas F, Shah B. Advances in Diagnosis and Management of Diffuse Large B-cell Lymphoma. Clin Lymphoma Myeloma Leuk 2017;17:783–96. Doi:10.1016/j.clml.2017.10.007.
18. Betzler AC, Brunner C. The Role of the Transcriptional Coactivator BOB.1/OBF.1 in Adaptive Immunity, 2024, p. 53–77. Doi:10.1007/978-3-031-62731-6_3.
19. Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K. Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood 2016;127:965–70. Doi:10.1182/blood-2015-06-651968.
20. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–90. Doi:10.1182/blood-2016-01-643569.
21. Offit K, Coco F Lo, Louie DC, Parsa NZ, Leung D, Portlock C, et al. Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma. New England Journal of Medicine 1994;331:74–80. Doi:10.1056/NEJM199407143310202.
22. Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998;92:3152–62.
Downloads
Published
License
Os direitos autorais para artigos publicados no Jornal Memorial da Medicina são do autor, com direitos de primeira publicação para a revista. Em virtude de aparecerem nesta revista de acesso público, os artigos são de uso gratuito, com atribuições próprias, em aplicações educacionais e não comerciais. O Jornal Memorial da Medcina permitirá o uso dos trabalhos publicados para fins não comerciais, incluindo direito de enviar o trabalho para bases de dados de acesso público. Os artigos publicados são de total e exclusiva responsabilidade dos autores. Há encargos para submissão no processamento de artigos (Articles Processing Charge - APC).
